| Heading: |
Levetiracetam |
| Question ID: |
1790832 |
| UIN: |
42885 |
| House: |
Commons |
| Date tabled: |
2025-03-31 |
| Asking Member ID: |
5150 |
| Asking Member display name: |
Samantha Niblett
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Samantha Niblett
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 March 2025 to Question 40872 on Epilepsy: Drugs, what steps he is taking to support patients whose neurologist has specified that Levetiracetam must come from Millfarm. |
| Is named day: |
true |
| Date of holding answer: |
|
| Date answered: |
2025-04-07 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department is not aware of any supply issues with levetiracetam tablets from the manufacturer, Milpharm. Pharmacies can obtain stocks from their usual wholesalers. |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |